scholarly journals Blood Biomarkers Associated with Cognitive Decline in Early Stage and Drug-Naive Parkinson’s Disease Patients

PLoS ONE ◽  
2015 ◽  
Vol 10 (11) ◽  
pp. e0142582 ◽  
Author(s):  
Jose A. Santiago ◽  
Judith A. Potashkin
2019 ◽  
Vol 9 (1) ◽  
Author(s):  
Galina Gramotnev ◽  
Dmitri K. Gramotnev ◽  
Alexandra Gramotnev

AbstractClinical and biochemical diversity of Parkinson’s disease (PD) presents a major challenge for accurate diagnosis and prediction of its progression. We propose, develop and optimize PD clinical scores as efficient integrated progression biomarkers for prediction of the likely rate of cognitive decline in PD patients. We considered 269 drug-naïve participants from the Parkinson’s Progression Marker Initiative database, diagnosed with idiopathic PD and observed between 4 and 6 years. Nineteen baseline clinical and pathological measures were systematically considered. Relative variable importance and logistic regressions were used to optimize combinations of significant baseline measures as integrated biomarkers. Parkinson’s disease cognitive decline scores were designed as new clinical biomarkers using optimally categorized baseline measures. Specificities and sensitivities of the biomarkers reached ~93% for prediction of severe rate of cognitive decline (with more than 5 points decline in 4 years on the Montreal Cognitive Assessment scale), and up to ~73% for mild-to-moderate decline (between 1 and 5 points decline). The developed biomarkers and clinical scores could resolve the long-standing clinical problem about reliable prediction of PD progression into cognitive deterioration. The outcomes also provide insights into the contributions of individual clinical and pathological measures to PD progression, and will assist with better-targeted treatment regiments, stratification of clinical trial and their evaluation.


2019 ◽  
Vol 266 (7) ◽  
pp. 1578-1587 ◽  
Author(s):  
Shuai Xu ◽  
Xin-Wei He ◽  
Rong Zhao ◽  
Wei Chen ◽  
Zhaoxia Qin ◽  
...  

2016 ◽  
Vol 634 ◽  
pp. 119-125 ◽  
Author(s):  
Yanbing Hou ◽  
Chunyan Luo ◽  
Jing Yang ◽  
Wei Song ◽  
Ruwei Ou ◽  
...  

2021 ◽  
Vol 7 (1) ◽  
Author(s):  
Sang-Won Yoo ◽  
Joong-Seok Kim ◽  
Ji-Yeon Yoo ◽  
Eunkyeong Yun ◽  
Uicheul Yoon ◽  
...  

AbstractOrthostatic hypotension (OH) is relatively common in the early stage of Parkinson’s disease (PD). It is divided into delayed OH and classical OH. Classical OH in PD has been investigated widely, however, the clinical implications of delayed OH in PD have seldom been studied. The purpose of this study is to characterize delayed OH in PD. A total of 285 patients with early drug-naïve PD were enrolled and divided into three groups according to orthostatic change: no-OH, delayed OH, and classical OH. The disease severity in terms of motor, non-motor, and cognitive functions was assessed. The cortical thickness of 82 patients was analyzed with brain magnetic resonance imaging. The differences among groups and linear tendency in the order of no-OH, delayed OH, and classical OH were investigated. Seventy-seven patients were re-evaluated. Initial and follow-up evaluations were explored to discern any temporal effects of orthostasis on disease severity. Sixty-four (22.5%) patients were defined as having delayed OH and 117 (41.1%) had classical OH. Between-group comparisons revealed that classical OH had the worst outcomes in motor, non-motor, cognitive, and cortical thickness, compared to the other groups. No-OH and delayed OH did not differ significantly. Linear trends across the pre-ordered OH subtypes found that clinical parameters worsened along with the orthostatic challenge. Clinical scales deteriorated and the linear gradient was maintained during the follow-up period. This study suggests that delayed OH is a mild form of classical OH in PD. PD with delayed OH has milder disease severity and progression.


2018 ◽  
Vol 60 (12) ◽  
pp. 1323-1333 ◽  
Author(s):  
Yanbing Hou ◽  
Ruwei Ou ◽  
Jing Yang ◽  
Wei Song ◽  
Qiyong Gong ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document